Overview
- 84 inspections across 76 sites are on record.
- 174 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-01-30.
At a glance
Inspections
84
Sites
76
Observations
174
Career since
Apr 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Safrel Pharmaceuticals LLC | 30 Jan 2026 | Foods & Cosmetics | View 483 → |
| GlaxoSmithKline LLC | 20 Jun 2023 | Human Drugs | |
| Interquim, S.A. de C.V. | 16 Dec 2022 | Human Drugs | On file |
| Bayer de Mexico, S.A. de C.V. | 9 Dec 2022 | Human Drugs | View 483 → |
| Lake Chemicals Private Limited | 9 Aug 2019 | Human Drugs | On file |
Sites inspected
Safrel Pharmaceuticals LLCDayton, United States1 insp.
GlaxoSmithKline LLCConshohocken, United States1 insp.
Interquim, S.A. de C.V.Cuautitlan Izcalli, Mexico1 insp.
Bayer de Mexico, S.A. de C.V.Lerma, Mexico1 insp.
Lake Chemicals Private LimitedBangalore, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael Serrano5 shared
Addam S Reynolds5 shared
Barbara J Wilimczyk-Macri5 shared
Nicholas A Violand4 shared
Lauren L Vajo4 shared
Paul L Bellamy3 shared
Jennifer Macmillan3 shared
Atul Agrawal3 shared
Adetutu M Gidado2 shared
Alan L Truong2 shared
Full investigator report
Get the verbatim findings behind Maria Estrella's 174 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site